About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 219 record(s)
Req # A-2019-02638
Generic job descriptions of the following positions within Global Affairs Canada office of International Humanitarian Assistance (MHD): Director General, Director, Deputy Director, Program Officer, Policy Officer, and Policy Analyst.Organization: Global Affairs Canada
August 2020
Req # A-2020-000015
Information as to whether or not the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017 is on “intellectual property hold” as described in section 6.2 of Health Canada’s Guidance Document on PatentedMedicines (Notice of Compliance) Regulations.Organization: Health Canada
August 2020
Req # A-2020-000089
Lost/stolen opioid drug products reported to Health Canada from January 1, 2010 to December 31, 2019 with one of these molecules: buprenorphine, butorphanol, codeine, fentanyl, hydrocodone, hydromorphone, meperidine, methadone, morphine, normethadone, opium, oxycodone, oxymorphone, pentazocine, tapentadol, and tramadol.Organization: Health Canada
August 2020
Req # A-2019-001225
Adverse Reaction Report (AER). Report number: E2B_02474320.Organization: Health Canada
August 2020
Req # A-2020-000168
Adverse Reaction Report (AER) for botulinum toxin A . Report number: E2B_02932672.Organization: Health Canada
August 2020
Req # A-2020-000175
Adverse Reaction Report (AER) for botulinum toxin A. Report number: E2B_02985683.Organization: Health Canada
August 2020
Req # A-2020-000248
Adverse Reaction Report (AER) for CLOPIDOGREL BISULFATE. Report number: 729743.Organization: Health Canada
August 2020
Req # A-2020-000336
Adverse Reaction Report (AER) for SARILUMAB. Report number: E2B_02917832.Organization: Health Canada
August 2020
Req # A-2020-000393
Adverse Reaction Report (AER) for PETHIDINE HYDROCHLORIDE. Report numbers: E2B_02732599, E2B_02732569.Organization: Health Canada
August 2020
Req # A-2020-000544
Adverse Reaction Report (AER) for SODIUM AUROTHIOMALATE. Report numbers: E2B_02888778, E2B_02923312, E2B_02952203.Organization: Health Canada
August 2020